Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against the other ...

The promise of integrated care is well understood: better patient outcomes, more efficient use of NHS resources and a more ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

A colonoscopy can help detect colorectal cancer early, greatly improving your prognosis. Sponsored by Optum Care Washington.

PGA Tour Commissioner Jay Monahan met with the media for nearly an hour on Tuesday at the Players Championship Media Center.

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Journal’s spring Aging Wellness Expo returns Saturday at South Point hotel-casino. The Aging Wellness Expo, Nevada’s largest ...